EFFECTS OF BUPROPION DURING SMOKING ABSTINENCE ON LORETA-ASSESSED FRONTAL LOBE ACTIVITY
Bupropion, an atypical antidepressant medication, is a well-documented efficacious smoking cessation aide, but little is known about the brain areas that are affected when smokers quit with and without use of bupropion. Findings indicate that nicotine withdrawal is associated with reductions in exec...
Main Author: | Ruehle, Matthew Allen |
---|---|
Format: | Others |
Published: |
OpenSIUC
2020
|
Online Access: | https://opensiuc.lib.siu.edu/dissertations/1879 https://opensiuc.lib.siu.edu/cgi/viewcontent.cgi?article=2883&context=dissertations |
Similar Items
-
Increased Temporal Lobe Beta Activity in Boys With Attention-Deficit Hyperactivity Disorder by LORETA Analysis
by: Ching-Tai Chiang, et al.
Published: (2020-06-01) -
Predictors of Relapse in a Bupropion Trial for Smoking Cessation in Recently-Abstinent Alcoholics: Preliminary Results Using an Aggregate Genetic Risk Score
by: John E. McGeary, et al.
Published: (2012-09-01) -
Predictors of Relapse in a Bupropion Trial for Smoking Cessation in Recently-Abstinent Alcoholics: Preliminary Results Using an Aggregate Genetic Risk Score
by: John E. McGeary, et al.
Published: (2012-01-01) -
Assessment of the effectiveness of sustained release Bupropion and intensive physician advice in smoking cessation
by: Singh Pranav, et al.
Published: (2010-01-01) -
The use of bupropion SR in cigarette smoking cessation
by: Scott Wilkes
Published: (2008-03-01)